LeMaitre Vascular (LMAT) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 2, 2025, with voting on three director nominees: CEO, President, and an independent director.

• Board recommends voting FOR all three nominees and disagrees with ISS's withhold recommendation.

• ISS's prior policy on board diversity influenced last year's voting but has since been halted.

• Stockholder outreach was conducted to gather feedback on governance and board composition.

Voting matters and shareholder proposals

• Election of three director nominees is the primary voting matter.

• Stockholders are encouraged to change their vote if they previously voted against the Board's recommendation.

Board of directors and corporate governance

• Board composition includes CEO, President, and an independent director with industry expertise.

• Previous board nominee faced a withhold vote due to diversity concerns; board retained him after review.

• Board engaged a search firm to address diversity but suspended the search to ensure legal compliance.